Cancer/Oncology

It's more than a test. 

It's informed clinical decision making.

 

For in vitro diagnostic use.

 

Football banner image
Football banner image
Football banner image

Biomarkers can play a crucial role throughout a patient's cancer journey

Biomarkers can assist with risk stratification, surveillance and diagnosis, as well as predicting and monitoring treatment response or assessing disease progression and recurrence.1 This information should be utilized alongside existing clinical and diagnostic findings to select appropriate treatment interventions for each patient. 


 

LEVERAGING ALGORITHMS TO HELP IMPROVE RISK-PREDICTION ACCURACY

With one out of every two people expected to get cancer during their lifetime there is a clear need to optimize diagnostic solutions to tackle key challenges in oncology management.2

A rising number of tests combine the insights derived from two or more biomarkers into an algorithm to generate a result. These are known as multianalyte assays with algorithmic analysis (MAAAs). This combination may help improve performance compared to using single biomarkers.

 

 

ASSAYS ENGINEERED TO PROVIDE RELIABLE ASSISTANCE IN CANCER MANAGEMENT

Abbott offers a wide variety of assays to assist in the risk-stratification, diagnosis and management for many types of cancers including, colon, liver, ovarian, breast, pancreatic, testicular, gastrointestinal, lung and prostate cancer

The oncology solutions from Abbott can help you reduce laboratory operational costs while maintaining the quality standards necessary to have a meaningful positive impact to the quality and cost of health care.

Visit our individual disease state pages to discover more about biomarker solutions

Stay informed banner image
Stay informed banner image
Stay informed banner image
Core Laboratory Menu and Systems

 

View and download the Core Laboratory menus to see the complete list of available assays and in development assays, categorized by instrument.

Some assays may not be available on all platforms or in all regions.

Explore

Immunoassays

Abbott's high-quality immunoassay menu helps laboratories meet requirements to be timely and precise with results.

Mild Traumatic Brain Injury

Learn how Abbott has helped physicians evaluate suspected mild traumatic brain injury (mTBI).

Alinity Family

Discover how Alinity uses powerful technology to help redefine and improve operational productivity and confidence in your laboratory.

References
  1. Henry NL: Henry NL, Hayes DF. Cancer biomarkers. Mol Oncol. 2012;6(2):140-146. doi:10.1016/j.molonc.2012.01.010. 
  2. NHS. 2022. Cancer Overview. Available at: https://www.nhs.uk/conditions/cancer/. Last accessed: 31 July 2023.